ID
40476
Beskrivning
A Safety and Efficacy Study of INC280 Alone, and in Combination With Erlotinib, Compared to Chemotherapy, in Advanced/Metastatic Non-small Cell Lung Cancer Patients With EGFR Mutation and cMET Amplification; ODM derived from: https://clinicaltrials.gov/show/NCT02468661
Länk
https://clinicaltrials.gov/show/NCT02468661
Nyckelord
Versioner (3)
- 2019-01-17 2019-01-17 -
- 2020-04-20 2020-04-20 -
- 2020-04-25 2020-04-25 -
Rättsinnehavare
Novartis Pharmaceuticals
Uppladdad den
25 april 2020
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Non-Small Cell Lung Cancer NCT02468661
Eligibility Non-Small Cell Lung Cancer NCT02468661
- StudyEvent: Eligibility
Beskrivning
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beskrivning
EGFR-TKI Generation Third Prior treatment
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C1443775
- UMLS CUI [1,2]
- C0079411
- UMLS CUI [1,3]
- C0205437
- UMLS CUI [1,4]
- C1514463
Beskrivning
Phase II of clinical trial only
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C2974289
- UMLS CUI [1,2]
- C1514463
- UMLS CUI [2,1]
- C1999216
- UMLS CUI [2,2]
- C0072453
- UMLS CUI [2,3]
- C1514463
- UMLS CUI [3,1]
- C1999216
- UMLS CUI [3,2]
- C0062534
- UMLS CUI [3,3]
- C2985566
- UMLS CUI [3,4]
- C1514463
Beskrivning
Phase II of clinical trial only
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C1707479
- UMLS CUI [1,2]
- C1443775
- UMLS CUI [1,3]
- C1514463
- UMLS CUI [2,1]
- C1707479
- UMLS CUI [2,2]
- C1514162
- UMLS CUI [2,3]
- C0392920
- UMLS CUI [2,4]
- C1514463
- UMLS CUI [3]
- C1708063
Beskrivning
Phase II of clinical trial only
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C1514463
- UMLS CUI [1,2]
- C1708063
- UMLS CUI [1,3]
- C0392920
- UMLS CUI [1,4]
- C1514162
Similar models
Eligibility Non-Small Cell Lung Cancer NCT02468661
- StudyEvent: Eligibility
C0677984 (UMLS CUI [1,2])
C0007131 (UMLS CUI [2,1])
C0027627 (UMLS CUI [2,2])
C3274204 (UMLS CUI [2])
C4289657 (UMLS CUI [3])
C0162789 (UMLS CUI [1,2])
C0072453 (UMLS CUI [2,1])
C1707513 (UMLS CUI [2,2])
C1443775 (UMLS CUI [1,2])
C0439661 (UMLS CUI [1,3])
C0079411 (UMLS CUI [1,4])
C0079411 (UMLS CUI [1,2])
C0205437 (UMLS CUI [1,3])
C1514463 (UMLS CUI [1,4])
C1514463 (UMLS CUI [1,2])
C1999216 (UMLS CUI [2,1])
C0072453 (UMLS CUI [2,2])
C1514463 (UMLS CUI [2,3])
C1999216 (UMLS CUI [3,1])
C0062534 (UMLS CUI [3,2])
C2985566 (UMLS CUI [3,3])
C1514463 (UMLS CUI [3,4])
C1443775 (UMLS CUI [1,2])
C1514463 (UMLS CUI [1,3])
C1707479 (UMLS CUI [2,1])
C1514162 (UMLS CUI [2,2])
C0392920 (UMLS CUI [2,3])
C1514463 (UMLS CUI [2,4])
C1708063 (UMLS CUI [3])
C1708063 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,3])
C1514162 (UMLS CUI [1,4])